Stocktoria

TENAX THERAPEUTICS, INC. TENX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1993-10-28 · LEI

TENAX THERAPEUTICS, INC. statistics & valuation

Market cap$356.5M
P / B3.7×
Return on equity-54.2%
Return on capital-58.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-256.30% -99.50% -120.20% -222.50% -213.00% -765.10% 740.00% -95.20% -19.10% -54.20% 2016201720182019202020212022202320242025
Shares outstanding
1.4M 1.4M 3.8M 6.7M 12.6M 1.3M 28648 298281 15.3M 39.2M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-188.20% -89.40% -106.00% -131.90% -143.40% -541.90% 324.50% -66.00% -18.20% -50.50% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$31.04 -$1.15 -$1.34 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-50.5%-18.2%-66.0%324.5%-541.9%-143.4%-131.9%-106.0%-89.4%-188.2%
Return on equity-54.2%-19.1%-95.2%740.0%-765.1%-213.0%-222.5%-120.2%-99.5%-256.3%
Current ratio14.5620.603.261.743.643.212.448.517.992.20

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.